公开(公告)号：US09610312B2

公开(公告)日：2017-04-04

申请号：US14426548

申请日：2013-09-02

申请人： JS BIO CO., Ltd.

发明人： Jong-Seog Kim ,  Wang-hyu Lee

IPC分类号： C12N1/20 ,  A61K36/258 ,  C12N1/14 ,  C12R1/79 ,  C12P1/02

CPC分类号： A61K36/258 ,  C12N1/14 ,  C12P1/02 ,  C12R1/79 ,  A61K2300/00

摘要： The present invention relates to a paecilomyces variotii var. brunneolus GPP1101B (microorganism deposit number KCTC 119938BP) isolated during a ginseng fermentation process, and a preparation using the same. According to the present invention, remarkable anticancer, immune regulation, mutation inhibition and antibacterial effects are obtained by injecting the strain or the preparation into a ginseng extract or into a red ginseng extract.

公开(公告)号：US20150224156A1

公开(公告)日：2015-08-13

申请号：US14426548

申请日：2013-09-02

申请人： JS BIO CO., LTD.

发明人： Jong-Seog Kim ,  Wang-hyu Lee

IPC分类号： A61K36/258 ,  C12P1/02 ,  C12R1/79

CPC分类号： A61K36/258 ,  C12N1/14 ,  C12P1/02 ,  C12R1/79 ,  A61K2300/00

摘要： The present invention relates to a paecilomyces variotii var. brunneolus GPP1101B (microorganism deposit number KCTC 119938BP) isolated during a ginseng fermentation process, and a preparation using the same. According to the present invention, remarkable anticancer, immune regulation, mutation inhibition and antibacterial effects are obtained by injecting the strain or the preparation into a ginseng extract or into a red ginseng extract.

摘要翻译： 本发明涉及一种拟青霉（Paecilomyces variotii var。 在人参发酵过程中分离的布鲁诺氏菌GPP1101B（微生物保藏号KCTC 119938BP）和使用其的制剂。 根据本发明，通过将菌株或制剂注射入人参提取物或红参提取物中可获得显着的抗癌，免疫调节，突变抑制和抗菌作用。